An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells

Immunotherapy of cancer envisions the adoptive transfer of T-cells genetically engineered with tumor-specific heterodimeric α/β T-cell receptors (TCRα/β). However, potential mispairing of introduced TCRα/β-chains with endogenous β/α-ones may evoke unpredictable autoimmune reactivities. A novel singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Knies, Diana, Klobuch, Sebastian, Xue, Shao-An, Birtel, Matthias, Echchannaoui, Hakim, Yildiz, Oezlem, Omokoko, Tana, Guillaume, Philippe, Romero, Pedro, Stauss, Hans, Sahin, Ugur, Herr, Wolfgang, Theobald, Matthias, Thomas, Simone, Voss, Ralf-Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008279/
https://www.ncbi.nlm.nih.gov/pubmed/27028870
http://dx.doi.org/10.18632/oncotarget.8385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008279/
https://www.ncbi.nlm.nih.gov/pubmed/27028870
http://dx.doi.org/10.18632/oncotarget.8385

Ejemplares similares